Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Noteableon Sep 22, 2021 9:36pm
174 Views
Post# 33903279

RE:RE:RE:Noteable ---is this more harry houdini stuff?

RE:RE:RE:Noteable ---is this more harry houdini stuff?Harry, .... MTNB's technology may be a potential solution for an oral remdesivir, which is an antiviral once infected. This technology will not replace vaccine injections since vaccines work by mounting the needed immune response to develop antibodies to a specific antigen which then prevents a viral infection from taking hold in the first place. As such, I am not aware of any vaccine that can be delivered by absorbtion in the gut. Vaccines do not function in the same way as antibiotics which are usually delivered orally, but can also be delivered intravenusly particulaly when the pathogenic infection is serious, systemic and needs to be rapidly eliminated by the agent, Intravenous antibiotic, for example, are given to patients whose infections are resistant to oral antibiotics or for infections that require high doses of antibiotics that cannot be taken orally.

So there is no way that this nano-encapsulation technology will replace vaccinations by injection, at least not in the near term.

https://www.nejm.org/doi/full/10.1056/nejmoa2007764

 
<< Previous
Bullboard Posts
Next >>